Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Watanabe

Showing results (91-100 of 217) with videos related to

Pageof 22
Sort By:
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interactionTakahiro Ochiya, Keizo Takenaga, Masataka Asagiri, et al.
Oncology Research|June 22, 2012
Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell linesMariko Watanabe, Kazumi Nakano, Tomiteru Togano, et al.
Tropical Medicine and Health|March 28, 2013
Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to JapanMasashi Otani, Katsuyuki Eguchi, Tatsuki Ichikawa, et al.
Carcinogenesis|April 16, 2005
In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemiaTakeo Ohsugi, Ryouichi Horie, Toshio Kumasaka, et al.
Biochemical and Biophysical Research Communications|September 26, 2009
Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cellsTomiteru Togano, Masataka Sasaki, Mariko Watanabe, et al.
The American Journal of Pathology|May 10, 2002
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cellsRyouichi Horie, Takuro Watanabe, Kinji Ito, et al.
Virology Journal|April 29, 2010
High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disordersDaisuke Sasaki, Yuko Doi, Hiroo Hasegawa, et al.
Retrovirology|May 7, 2005
Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activationMasaya Higuchi, Takehiro Matsuda, Naoki Mori, et al.
Scientific Reports|December 8, 2015
Coordinated loss of microRNA group causes defenseless signaling in malignant lymphomaMakoto Yamagishi, Harutaka Katano, Tsunekazu Hishima, et al.
The American Journal of Pathology|July 24, 2003
AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cellsMariko Watanabe, Yuji Ogawa, Kinji Ito, et al.
Pageof 22

Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interactionTakahiro Ochiya, Keizo Takenaga, Masataka Asagiri, et al.
Oncology Research|June 22, 2012
Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell linesMariko Watanabe, Kazumi Nakano, Tomiteru Togano, et al.
Tropical Medicine and Health|March 28, 2013
Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to JapanMasashi Otani, Katsuyuki Eguchi, Tatsuki Ichikawa, et al.
Carcinogenesis|April 16, 2005
In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemiaTakeo Ohsugi, Ryouichi Horie, Toshio Kumasaka, et al.
Biochemical and Biophysical Research Communications|September 26, 2009
Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cellsTomiteru Togano, Masataka Sasaki, Mariko Watanabe, et al.
The American Journal of Pathology|May 10, 2002
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cellsRyouichi Horie, Takuro Watanabe, Kinji Ito, et al.
Virology Journal|April 29, 2010
High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disordersDaisuke Sasaki, Yuko Doi, Hiroo Hasegawa, et al.
Retrovirology|May 7, 2005
Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activationMasaya Higuchi, Takehiro Matsuda, Naoki Mori, et al.
Scientific Reports|December 8, 2015
Coordinated loss of microRNA group causes defenseless signaling in malignant lymphomaMakoto Yamagishi, Harutaka Katano, Tsunekazu Hishima, et al.
The American Journal of Pathology|July 24, 2003
AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cellsMariko Watanabe, Yuji Ogawa, Kinji Ito, et al.
Pageof 22